Menu

Experience

Christian Plaza

    • PhaseBio Pharmaceuticals – $46 Million IPO 


    • Entasis Therapeutics – $75 Million IPO 


    • Autolus – $173 Million IPO 


    • Sucampo Sells to Mallinckrodt for $1.2 Billion 


    • Cardioxyl Pharmaceuticals sale to Bristol-Myers Squibb 


    • First US IPO of 2014 for GlycoMimetics 


Contact us

Back to top

© 2019 Cooley LLP and Cooley (UK) LLP. All rights reserved.

Cooley® is a registered service mark of Cooley LLP in the United States and European Union as well as certain other jurisdictions.